FDA finds that there is no reliable evidence showing that drugs with progesterone cause birth defects.
A new system of symbols to communicate patient conditions relies on visuals.
Check this list to be sure you are consulting the most up-to-date medical packaging standardï¿½or find one you havenï¿½t used before.
Proper submission and regular maintenance of Drug Master Files are gaining a new level of importance for any company that wants to successfully supply the Mexican pharma market.
Experts think FDA's new drug name approval processs is a work in progress. Could packaging help?
An attempt to streamline FDA’s name approval process for new drugs has prompted responses. In June, FDA accepted feedback from industry leaders for its Pilot Program to Evaluate Proposed Name Submissions to consider new terms for approval.